首页/数据集/Supporting Information S1 - Circulating miRNAs as Potential Marker for Pulmonary Hypertension

Supporting Information S1 - Circulating miRNAs as Potential Marker for Pulmonary Hypertension

NIAID Data Ecosystem2026-03-07 收录

数据链接：

https://figshare.com/articles/dataset/_Circulating_miRNAs_as_Potential_Marker_for_Pulmonary_Hypertension_/706667 数据链接链接失效反馈

官方服务：

资源简介：

Patients Profile. (PDF)

应用场景：

创建时间：

2013-05-23

肺动脉高压生物标志物

代谢分子机制

Additional file 2. Supplementary Table 2. The ROC values and 95% confidence intervals of 28 module DE-CMGs.

Figshare2024-08-13 更新70

AUC of miRNA panel in the training set and validation set.

miRNA诊断

生物标志物评估

A: AUC for the miRNA panel in the training set and B: AUC of the miRNA panel in the validation set.

NIAID Data Ecosystem50

Screening of key biomarkers and immune infiltration in Pulmonary Arterial Hypertension via integrated bioinformatics analysis

肺动脉高压生物标志物

免疫微环境分析

This study aimed to screen key biomarkers and investigate immune infiltration in pulmonary arterial hypertension (PAH) based on integrated bioinformatics analysis. The Gene Expression Omnibus (GEO) da

NIAID Data Ecosystem20

Alterations in Plasma Metabolites in Pulmonary Arterial Hypertension Secondary to Congenital Left-to-Right Shunt Heart Disease

先天性心脏病代谢组学

肺动脉高压生物标志物

Pulmonary arterial hypertension (PAH) secondary to congenital left-to-right shunt heart disease (CL-RSHD) involves vascular remodeling, metabolic dysregulation, chronic inflammation, immune dysfunctio

Figshare2024-10-01 更新60

The down-regulated lncRNAs in the PAH groups compared to the control groups.

肺动脉高压生物标志物

差异表达lncRNA分析

The down-regulated lncRNAs in the PAH groups compared to the control groups.

NIAID Data Ecosystem30